Microbicide trial screeches to a halt

Journal of Clinical Investigation

Volumn 117, Issue 5, 2007, Pages 1116-

  Honey, Karen ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CELLULOSE SULFATE; MICROBICIDE; NONOXINOL 9; PLACEBO;

CELL SURFACE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; GEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; INFECTION RISK; MEDICAL RESEARCH; NON PROFIT ORGANIZATION; NOTE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VAGINA DISEASE; VAGINA MUCOSA LESION; VIRUS ENVELOPE;

ANTI-HIV AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; CELLULOSE; DOUBLE-BLIND METHOD; FEMALE; HIV INFECTIONS; HUMANS;

EID: 34248198301     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI32291     Document Type: Note

References (2)

1. Check, E. 2007. Scientists rethink approach to HIV gels. Nature. 446:12.
2. Gawrylewski, A. 2007. Failure of HIV microbicide raises concerns. The scientist. http://www.the-scientist.com/news/home/52861/.